Why is Guj. Terce Labs. falling/rising?

As of 28-Aug, Gujarat Terce Laboratories Ltd is currently priced at 41.50, reflecting an increase of 0.24 or 0.58%. The stock has shown a trend reversal by gaining after two consecutive days of decline and has outperformed its sector by 1.42% today. However, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally bearish trend. Over the past week, the stock has decreased by 5.42%, and over the past month, it has fallen by 13.54%. The company's financial health is concerning, with operating losses and a weak ability to service its debt, as evidenced by a poor EBIT to Interest ratio of 0.02. Additionally, the stock has generated a return of -24.67% over the past year, with profits plummeting by 164.4%.
In the broader market context, the stock has underperformed significantly compared to the benchmark, with the BSE500 index showing a negative return of only 5.01% over the same period. This stark contrast highlights the challenges faced by Gujarat Terce Laboratories Ltd, particularly given its substantial decline in net sales and operating profit. Despite a recent increase in investor participation, as indicated by a 170.59% rise in delivery volume, the overall sentiment remains negative due to the company's weak long-term fundamentals and high valuation relative to its peers.